H. Lightstone
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
-
- Computational Drug Discovery Methods
Papers in
-
- Nicotinic Acetylcholine Receptors Study 2
- Phosphodiesterase function and regulation 1
-
- Cholinesterase and Neurodegenerative Diseases 5
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Bert N. La Du (5 shared papers)Cynthia F. Bartels (4 shared papers)Oksana Lockridge (4 shared papers)Cristina Nogueira (4 shared papers)A K Hajra (2 shared papers)Martine Arpagaus (1 shared paper)S.L. Primo-Parmo (1 shared paper)T Lubrano (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Clinical Biochemistry (1 paper)PubMed (2 papers)Journal of the American Pharmaceutical Association (Scientific ed ) (1 paper)Pharmacogenetics (1 paper)
- Partner nations
- United StatesGreece
In The Last Decade
H. Lightstone
6 papers receiving 312 citations
Peers
Comparison fields: 5 of 55
- Pharmacology 245
- Computational Theory and Mathematics 129
- Pharmacology 47
- Anesthesiology and Pain Medicine 15
- Complementary and alternative medicine 17
Countries citing papers authored by H. Lightstone
This map shows the geographic impact of H. Lightstone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lightstone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lightstone more than expected).
Fields of papers citing papers by H. Lightstone
This network shows the impact of papers produced by H. Lightstone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lightstone. The network helps show where H. Lightstone may publish in the future.
Co-authors
The 12 scholars most cited alongside H. Lightstone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 150 | |
| 2 | 1990 | 60 | |
| 3 | Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT----GGAG). | 1990 | 55 |
| 4 | Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase. | 1992 | 37 |
| 5 | 1997 | 15 | |
| 6 | 1954 | 5 |
About H. Lightstone
H. Lightstone is a scholar working on Molecular Biology, Pharmacology, Computational Theory and Mathematics, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 6 papers that have together received 322 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (5 papers), Computational Drug Discovery Methods (3 papers), Nicotinic Acetylcholine Receptors Study (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Chemical synthesis and alkaloids (1 paper), Medicinal Plants and Neuroprotection (1 paper), Phosphodiesterase function and regulation (1 paper) and Anesthesia and Sedative Agents (1 paper). The work is most often cited by research in Pharmacology (245 citations), Computational Theory and Mathematics (129 citations), Pharmacology (47 citations), Anesthesiology and Pain Medicine (15 citations) and Complementary and alternative medicine (17 citations). H. Lightstone has collaborated with scholars based in United States and Greece. Frequent co-authors include Bert N. La Du, Cynthia F. Bartels, Oksana Lockridge, Cristina Nogueira, A K Hajra, Martine Arpagaus, S.L. Primo-Parmo, T Lubrano, H M Rubinstein and S. Adkins. Their work appears in journals such as Proceedings of the National Academy of Sciences, Clinical Biochemistry, PubMed, Journal of the American Pharmaceutical Association (Scientific ed ) and Pharmacogenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.